Prevalence of Keratoconus in Inflammatory Bowel Diseases
NCT ID: NCT02861339
Last Updated: 2016-08-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
201 participants
INTERVENTIONAL
2014-02-28
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary purpose is to search for a relationship between the presence of a keratoconus and activity criteria of IBD.
Perspectives are a systematic screening for keratoconus in patients affected by IBD with the amelioration of the ophthalmologic care of IBD patients and confirmation of the recent hypothesis of inflammatory origin of keratoconus.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ocular Manifestations of Inflammatory Bowel Disease
NCT04771039
Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk
NCT02193464
The Value of I-Scan and Confocal Laser Endomicroscopy for the Assessment of Chronic Inflammatory Bowel Disease
NCT02481687
Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel Diseases
NCT02878395
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
NCT05598489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Keratoconus and IBD
Opthalmologic measure with DM OPD scan III (Nidek)
Opthalmologic measure with DM OPD scan III (Nidek)
Bilateral measure of corneal refractometry, pachymetry, topography and aberrometry
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Opthalmologic measure with DM OPD scan III (Nidek)
Bilateral measure of corneal refractometry, pachymetry, topography and aberrometry
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Affiliation to social security plan
* Diagnosis of IBD since more than 3 years, under treatment or not
Exclusion Criteria
* Pregnant or breastfeeding women
* Person in life-and-death emergency
* Person deprived of liberty
* Refusal to remove contact lenses, where necessary
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karine ANGIOI-DUPREZ
Role: PRINCIPAL_INVESTIGATOR
Service d'ophtalmologie- Hôpitaux de Brabois - CHU de NANCY
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-A01680-45
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.